Abiopharma

🔍 JENKINS DAVID A (Executive)

Company: Catheter Precision, Inc. (VTAK)

Report Date: 2025-12-31

Detailed Transactions and Holdings:

• Acquired 170,000 shares of Series M Common Stock Purchase Warrant at $1.56 per share (Derivative)
  Date: 2025-12-31 | Code: J | equity_swap_involved: 0 | shares_owned_after: 170,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 170,000 shares of Series M Common Stock Purchase Warrant at $1.56 per share (Derivative)
  Date: 2025-12-31 | Code: J | equity_swap_involved: 0 | shares_owned_after: 170,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: Initial Exercise Date is any time on or after the Stockholder Approval Date.
• F2: Termination Date equals the Five and One Half (5.5) Year Anniversary of the Initial Exercise Date
• F3: Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP